Almirall S.A (E2Z F) stock market data APIs
€10.5863
0(0%)
as of July 4, 2025
Try our APIs with
free plan!
Almirall S.A Financial Data Overview
Price chart is built with
Anychart
Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, nervous, and respiratory system; dermatologicals; genito urinary system and sex hormones; immunostimulants; metabolism; and systematic hormonal preparations. It has a multi-target partnership with Etherna to research and develop mRNA-based therapies for medical dermatology. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.
Prev. Close
10.5863
Open
10.5863
High
10.5863
Low
10.5863
52 wk Range
7.9466-11.28
Market Cap
2 270 M
P/E Ratio
87.6667
Shares Outstanding
215 M
Revenue
1 028 M
Dividends (Yield)
0.0173
Beta
0.298
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Almirall S.A data using free add-ons & libraries
Get Almirall S.A Fundamental Data
Almirall S.A Fundamental data includes:
- Net Revenue: 1 028 M
- EBITDA: 192 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Almirall S.A News
New
3 European Stocks That May Be Undervalued Based On Current Market Estimates
As the pan-European STOXX Europe 600 Index remains relatively flat and major stock indexes show mixed returns, investors are keeping a close eye on economic indicators such as eurozone inflation reach...
Global Market Insights Three Stocks Possibly Trading Below Estimated Value
As global markets recently celebrated record highs, driven by easing geopolitical tensions and positive trade developments, investors are keenly observing opportunities amidst fluctuating economic ind...
European Stocks That May Be Trading Below Estimated Value In July 2025
As the European markets show signs of recovery, with the STOXX Europe 600 Index climbing 1.32% and Germany's DAX up by nearly 3%, investor optimism is bolstered by easing geopolitical tensions and pot...
3 Global Stocks Estimated To Be Trading Below Fair Value In May 2025
As global markets react positively to the recent U.S.-China tariff suspension, with major indices such as the Nasdaq Composite and S&P 500 showing significant gains, investors are keenly observing how...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
